.

Moderna Inc traded at $120.99 this Monday October 3rd, increasing $2.74 or 2.32 percent since the previous trading session. Looking back, over the last four weeks, Moderna Inc gained 6.99 percent. Over the last 12 months, its price fell by 62.87 percent. Looking ahead, we forecast Moderna Inc to be priced at 114.70 by the end of this quarter and at 104.69 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
120.99
Daily Change
2.32%
Yearly
-62.87%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 17.04 0.68 4.16% 1.49%
Acorda Therapeutics 0.34 0.04 12.71% -92.39%
Agios Pharmaceuticals 28.98 0.70 2.48% -36.35%
Alnylam Pharmaceuticals 196.79 -3.37 -1.68% 0.91%
Amgen 230.44 5.04 2.24% 8.99%
Arrowhead Research 33.74 0.69 2.09% -45.32%
Biogen 264.30 -2.70 -1.01% -5.04%
Bluebird Bio 6.13 -0.20 -3.16% -66.76%
BioMarin Pharmaceutical 86.70 1.93 2.28% 14.26%
Esperion Therapeutics 6.55 -0.15 -2.24% -44.16%
Gilead Sciences 62.32 0.63 1.02% -7.76%
GlaxoSmithKline 1,319.60 13.80 1.06% -4.71%
Intercept Pharmaceuticals 13.48 -0.47 -3.37% -9.83%
Incyte Corp 68.83 2.19 3.29% 3.78%
Ionis Pharmaceuticals 44.99 0.76 1.72% 39.16%
Mirati Therapeutics 68.36 -1.48 -2.12% -59.71%
Puma Biotechnology 2.39 0.02 0.84% -61.88%
Ultragenyx Pharmaceutical 41.93 0.52 1.26% -50.66%
Regeneron Pharmaceuticals 734.93 46.26 6.72% 32.32%
Seattle Genetics 137.70 0.87 0.64% -20.49%
Sangamo BioSciences 4.78 -0.12 -2.45% -45.74%
Sarepta Therapeutics 109.94 -0.60 -0.54% 16.14%
United Therapeutics 213.93 4.55 2.17% 15.41%
Vertex Pharmaceuticals 297.43 7.89 2.73% 68.03%

Indexes Price Day Year
USNDX 11313 258.50 2.36% -22.91%

Moderna Inc
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company has created modalities, including Prophylactic vaccines, Systemic secreted and cell surface therapeutics, Cancer vaccines, Intratumoral immuno-oncology, Localized regenerative therapeutics, and Systemic intracellular therapeutics. Its diverse development pipeline which consists of 27 development candidates across its 24 programs.